CINECA IRIS Institutional Research Information System

GAMBALE, CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.910
AS - Asia 1.171
EU - Europa 1.031
SA - Sud America 224
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.438
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.854
SG - Singapore 432
IT - Italia 360
CN - Cina 342
DE - Germania 220
HK - Hong Kong 192
BR - Brasile 186
AT - Austria 82
SE - Svezia 79
GB - Regno Unito 56
VN - Vietnam 51
FI - Finlandia 47
CI - Costa d'Avorio 43
BG - Bulgaria 38
FR - Francia 38
CA - Canada 32
IN - India 29
TR - Turchia 26
RU - Federazione Russa 24
KR - Corea 22
SN - Senegal 22
JP - Giappone 20
PL - Polonia 18
AR - Argentina 16
EE - Estonia 14
MA - Marocco 14
MX - Messico 14
NL - Olanda 13
ZA - Sudafrica 9
BD - Bangladesh 8
ES - Italia 8
PK - Pakistan 7
UA - Ucraina 7
IQ - Iraq 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
IR - Iran 5
LT - Lituania 5
MG - Madagascar 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CL - Cile 4
PE - Perù 4
CY - Cipro 3
GR - Grecia 3
HU - Ungheria 3
JO - Giordania 3
NP - Nepal 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BO - Bolivia 2
GT - Guatemala 2
ID - Indonesia 2
IE - Irlanda 2
JM - Giamaica 2
OM - Oman 2
SA - Arabia Saudita 2
SV - El Salvador 2
UY - Uruguay 2
AO - Angola 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
HN - Honduras 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TG - Togo 1
ZM - Zambia 1
Totale 4.438
Salva come PNG Salva come JPEG
Città #
Dallas 386
Ashburn 274
Singapore 257
Hong Kong 184
Santa Clara 140
Chandler 126
San Jose 115
Milan 99
New York 79
Shanghai 77
Vienna 75
Munich 71
Beijing 68
Los Angeles 63
Fairfield 47
Pisa 47
Abidjan 43
Boardman 38
Sofia 38
Hefei 34
Seattle 30
Rome 29
Wilmington 27
Houston 26
Helsinki 24
Cambridge 23
Woodbridge 23
Dakar 22
Florence 22
Frankfurt am Main 22
Princeton 22
Seoul 21
Redondo Beach 20
Lawrence 19
São Paulo 19
Turku 18
Tokyo 17
Buffalo 14
Denver 14
London 13
Hanoi 12
Belo Horizonte 11
Casablanca 11
Cascina 11
Fuzhou 11
Lucca 11
Dong Ket 10
Istanbul 10
Medford 10
Serra 10
Warsaw 10
Boulder 9
Brooklyn 9
Montreal 9
Poplar 9
Ann Arbor 8
Ho Chi Minh City 8
Johannesburg 8
Mexico City 8
San Diego 8
Düsseldorf 7
Livorno 7
Ogden 7
Quanzhou 7
Stockholm 7
Vancouver 7
Atlanta 6
Bologna 6
Brasília 6
Chicago 6
Nuremberg 6
Ottawa 6
Toronto 6
Vicopisano 6
Antananarivo 5
Bremen 5
Nanjing 5
Orem 5
Rio de Janeiro 5
Samsun 5
Tashkent 5
Washington 5
Xiamen 5
Zhengzhou 5
Baghdad 4
Baku 4
Boston 4
Brno 4
Chengdu 4
Dearborn 4
Guangzhou 4
Lima 4
Mumbai 4
Amman 3
Amsterdam 3
Ankara 3
Atakum 3
Athens 3
Bari 3
Budapest 3
Totale 3.076
Salva come PNG Salva come JPEG
Nome #
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 223
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 222
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 183
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 167
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 164
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 163
The Thymic Hyperplasia (TH) And Biochemical Persistence Of Disease In Patients With Differentiated Thyroid Carcinoma (DTC) 152
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 145
Thyroid cancers: From surgery to current and future systemic therapies through their molecular identities 144
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 139
Recombinant Human Thyrotropin Stimulation Thyroglobulin (rhTSH-Tg) test can identify false serum tg due to heterophilic antibodies in differentiated thyroid cancer (DTC) patients 136
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 135
Systemic treatment of advanced, metastatic, medullary thyroid carcinoma 134
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 131
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia 127
Radioiodine remnant ablation (RRA) Impact on the dynamic risk of restratification in the short-term follow-up of patients with differentiated thyroid cancer (DTC). 120
Predictive Value Of High Sensitive Thyroglobulin Assay (USTG) And Neck Ultrasonography (US) At The Time Of Remnant Ablation On Lt-4 Therapy In Patients With Low And Intermediate Risk Differentiated Thyroid Cancer (DTC) 118
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series 114
Effect of Pregnancy and Menopause on Micropapillary Thyroid Carcinomas During Active Surveillance 114
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 113
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response 107
Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib 106
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 103
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature 102
NF1 Gene Inactivation Acts as Tumor Driver in RET/RAS Negative Medullary Thyroid Carcinomas 99
Management and follow-up of differentiated thyroid cancer not submitted to radioiodine treatment: a systematic review 99
Hypothesizing a role of ret hyperactivation on weight control in patients with type 2A multiple endocrine neoplasia (MEN2A) 96
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 96
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma 94
Erectile dysfunction in patients treated with selpercatinib for RET altered thyroid cancer 93
BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review 79
Ultrasound features and risk stratification system in NIFT-P and other follicular-patterned thyroid tumors 76
Insights into Ultrasound Features and Risk Stratification Systems in Pediatric Patients with Thyroid Nodules 72
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 72
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine 72
Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib 68
Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients 64
Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib 54
Timing and Ideal Patient for an Appropriate Search for Somatic RET Mutation in Medullary Thyroid Cancer 41
Totale 4.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202180 0 0 0 0 0 0 9 7 8 11 23 22
2021/2022167 1 4 5 2 31 28 5 8 9 7 13 54
2022/2023497 32 56 51 36 54 54 20 44 109 5 29 7
2023/2024468 42 56 70 39 62 76 21 7 13 9 30 43
2024/20251.407 26 43 28 82 148 126 129 65 135 161 160 304
2025/20261.543 167 346 274 233 236 137 150 0 0 0 0 0
Totale 4.537